Catalent, Inc.
(NYSE : CTLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -1.16%249.022.8%$140.26m
VRXValeant Pharmaceuticals International, Inc. -5.47%23.6914.1%$139.40m
HZNPHorizon Therapeutics Plc -2.35%84.395.4%$111.17m
CTLTCatalent, Inc. -3.36%98.652.0%$104.09m
BHCBausch Health Cos., Inc. -5.57%23.670.0%$101.88m
JAZZJazz Pharmaceuticals Plc -4.31%130.872.1%$83.82m
SAVACassava Sciences, Inc. -2.48%35.430.0%$83.42m
UTHRUnited Therapeutics Corp. -0.56%198.9413.9%$78.43m
ZGNXZogenix, Inc. -0.14%25.957.5%$77.82m
PRGOPerrigo Co. Plc -4.02%37.286.9%$47.24m
ARGXargenx SE -5.02%265.230.0%$45.99m
BRBRBellRing Brands, Inc. 5.32%25.720.0%$27.57m
PCRXPacira Biosciences, Inc. -4.05%60.869.8%$27.51m
IRWDIronwood Pharmaceuticals, Inc. 0.14%11.019.5%$22.85m
SAGESAGE Therapeutics, Inc. -3.66%36.817.6%$17.25m

Company Profile

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy; formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The Oral and Speciality Delivery segment consists of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment involves packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.